相关实验视频

Updated: Jun 4, 2025

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

利用全球HLA数据,在iPSC哈普洛银行中增强患者匹配

Martin Maiers¹, Stephen Sullivan², Christopher McClain³

¹CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, Minnesota, USA.

|December 24, 2024

概括

诱导多能干细胞 (iPSC) 哈普洛库的全球战略可以显著改善患者的HLA匹配覆盖率. 这种方法使用优先级列表的HLA单元类型,为国家银行提供了更有效的替代方案,可能会使治疗的可访问性翻一番.

科学领域:

免疫遗传学免疫遗传学
再生医学是一种再生医学.
这是生物银行.

背景情况:

国家诱导多能干细胞 (iPSC) 银行使用特定人群的HLA同胞性基因型来匹配患者的再生疗法.
"哈普洛银行"方法需要了解当地的HLA基因型,以确定患者覆盖的有益的哈普洛型.

研究的目的:

开发一个算法来优先考虑HLA类型,以优化全球患者覆盖范围.
评估一个单一的全球哈普银行作为国家银行更有效的替代品的可行性.

主要方法:

通过全球iPS治疗联盟 (GAiT) 来分析来自18个国家的HLA基因型数据.
开发了一种算法,优先考虑HLA-A, -B和-DRB1同卵性哈普洛类型,以获得最大的患者覆盖率,最大限度地减少主与移植 (HvG) 不匹配.
代选择的哈普洛类型提供了最大的覆盖范围与采样患者的基因型.

主要成果:

每个国家的前10个单元类型提供了19.5%至63.8%的覆盖率 (平均33.3%).
使用前180个单元型的全球模型实现了54.6%至81.7%的覆盖率 (平均68.4%),超过了潜在患者HLA匹配的两倍.
全球180个顶级单质类型的同卵性捐赠者在注册表和带血库中广泛可用.

结论:

全球协调的哈普银行策略比国家方法更有效.
实施全球的哈普洛银行减少了冗余,并增加了患者获得免疫匹配细胞和组织的机会.
这一策略通过优化HLA匹配,提高了通过再生医学疗法治疗更多患者的潜力.

关键词:

哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈所有的异构物质都是异构的.哈普罗银行是哈普罗银行.他的兼容性与不兼容性.这就是 iPSC 的意义.登记处的注册表可以看到.

更多相关视频

Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells

Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells

Published on: April 18, 2019

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...